“Why?” Jake asked.
It was 3:17 AM in the Medical ICU when the pagers went off. “Bed 4, ABG in 20.”
Maya answered, “Because tocilizumab blocks IL-6 receptors. It can lower CRP dramatically—but it can also mask signs of superinfection. The ABG will tell us if her oxygenation improves or if she’s silently getting worse.” abg tocil
“Yes. But look at her CRP and IL-6 from this morning. They’ve tripled.” Maya scrolled through the chart. “She’s not just fatigued. She’s in a cytokine storm.”
Jake checked. “She’s not triggering.” “Why
But Maya stared at the chart. “Look at the PaCO₂. 38. That’s low for a paralyzed patient. She’s breathing over the vent.”
That’s when the attending, Dr. Vance, appeared. He glanced at the ABG. “Call pharmacy. She gets now. But first—we need one more ABG post-intubation, then another 6 hours after tocilizumab.” It can lower CRP dramatically—but it can also
That night, Maya wrote in her note: ABG tocilizumab — a story of two drugs. One tells you the gas exchange. The other changes the rules of inflammation. Together? They can save a life—if you know how to read between the lines.